NLRP3 and diabetes mellitus: Shahzad and colleagues also demonstrated that inhibiting the IL-1 receptor by Anakinra thereby blocking one of the effector molecules of NLRP3 inflammasome activation, IL-1β, prevented or even reversed diabetes associated albuminuria and mesangial expansion in streptozotocin diabetic and db/db diabetic mice [5].